Patent · US Active

Method of identifying membrane IgE specific antibodies and use thereof for targeting IgE producing precursor cells

US8137670B2 · kind B2 · utility

7Cited by
27References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 28, 2006
Grant dateMar 20, 2012
Priority date
Expiry dateNov 12, 2028

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S530/868
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to the discovery of antibodies that bind to novel epitopes present on membrane-anchored IgE and which bind to these novel epitopes on the surface of B cells and plasma cells. In addition, the antibodies of the present invention can mediate ADCC and can be useful to deplete those B cells and plasma cells expressing the novel epitopes of the invention. The antibodies of the present invention can be useful for the treatment of IgE-mediated diseases. Accordingly the present invention also provides compositions and methods for the prevention, management, treatment or amelioration of IgE-mediated diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.